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Substance P (SP) and its preferred neurokinin-1 (NK1) 
receptor play a significant role in stress and anxiety-related 
behaviors.  While the influence of the NK1 receptor on 
stress responses is well documented, less is known about 
its role in reward and addiction.  Recent studies have 
suggested a critical role of the SP/NK1 system in the 
rewarding properties of morphine, but not that of cocaine.  
Furthermore, our lab was the first to demonstrate that 
alcohol consumption is decreased by a genetic deletion of 
the NK1 gene in mice, and that administration of NK1 
antagonists to human alcoholics can alleviate craving.  In 
the studies presented here, we utilize the well-validated 
models of rat self-administration and reinstatement to 
assess the effects of a specific NK1 antagonist, L822429.  
This antagonist has anxiolytic properties in rodent models 
when administered systemically, and therefore represents 
an intriguing agent for altering alcohol-related behaviors.  
NK1 antagonism has presented a rather complicated target 
thus far, as receptor affinity shows significant interspecies 
variation and many antagonists that are effective in humans 
are inactive in rat.  We found that while L822429 had little 
effect on baseline alcohol self-administration or cue-induced 
reinstatement of alcohol seeking behavior, it dose-
dependently blocked the expression of stress-induced 
reinstatement.  Importantly, this drug had no effect on 
locomotor activity or self-administration of sucrose solution.  
To our knowledge, this is the first exploration of the effects 
of NK1 receptor antagonists on alcohol-related behaviors in 
rats.  Taken together, these results indicate NK1 antagonists 
generally, and L822429 specifically, as promising 
candidates for pharmacotherapy for alcoholism.
-Substance P (SP) is a neuropeptide that signals 
primarily through the neurokinin-1 (NK1) receptor 
and is highly involved in stress, anxiety, and 
addiction1-2.
-Manipulations of the SP/NK1 system have been 
shown to impact rewarding and reinforcing 
properties of morphine, but not cocaine3-5. 
-NK1 -/- mice drink less alcohol, show blunted 
alcohol associated reward, and do not escalate 
alcohol consumption following intermittent 
access6-7.
-NK1 antagonists decrease alcohol consumption 
in wildtype mice and attenuate craving in 
alcoholics6-7.
-L822429 is a highly specific NK1 antagonist that 
has central activity when delivered systemically 
and has anxiolytic properties8-9.
-The studies outlined here attempt to assess 
the effect of L822429 on alcohol self-
administration and reinstatement.
-L822429 induces a small, but 
statistically significant, reduction 
in alcohol self administration.
-L822429 induced a potent, 
dose dependent suppression of 
alcohol seeking behavior during 
footshock-induced 
reinstatement testing. However, 
this drug does not affect cue-
induced reinstatement of 
alcohol seeking behavior.
-L822429 does not effect self-
administration of 10% sucrose 
or general locomotor activity 
(data not shown).
-The experiments outlined 
above indicate an important role 
of the NK1 receptor in alcohol-
induced behaviors.
Animals: Male Wistar rats weighing approximately 400 to 500 grams at the time of experimentation were used in these studies. Rats were housed in a reversed light cycle (lights on 20:30, 
lights off 08:30), and all testing took place during the dark phase.
Alcohol Self-Administration: 10% ethanol (v/v) was available during self-administration sessions on an FR1 schedule.  Alcohol was dissolved in tap water and delivered in a 0.1 ml 
volume onto a tray within the self-administration chamber, from which the rat consumed the alcohol solution. A 5 second time out was initiated following alcohol delivery during which a 
house light was illuminated.  During time out, alcohol delivery was not activated following active lever press, but these responses were recorded.  Following the timeout, the session 
returned to the FR1 schedule of reinforcement.  For cue-induced reinstatement experiments, orange scent was also present in the self-administration chambers during alcohol sessions. 
Self-Administration Experiments:  After a stable level of responding was reached for at least three consecutive days, rats were injected with L822429 (0, 15, or 30 mg/kg) 60 minutes 
before the next self-administration session.
Extinction & Reinstatement:  After 14-16 days of self-administration, extinction sessions were begun where responding on the active lever did not result in a delivery of alcohol. In the 
stress-induced reinstatement experiment, the time out light cue remained in place during the extinction sessions.  For the cue-induced reinstatement experiment, the light cue and orange 
scent were removed during extinction sessions.  Extinction conditions were in place for 15-19 sessions.  To reinstate responding, specific stimuli were delivered to induce active lever 
pressing behavior.  In the stress-induced reinstatement experiment, 15 minutes of intermittent footshock (0.5 sec shock, 0.6 mA) was delivered immediately before the reinstatement 
session.  In cue-induced reinstatement experiments, presentation of orange scent and contingent house light illumination served as the reinstatement stimuli.  In both experiments L822429 
was injected 60 minutes prior to reinstatement testing.   
Drugs:  L822429 was synthesized from the literature by K. Rice and K. Cheng.  L822429 was dissolved in 45% (w/v) 2-hydroxypropyl β-cyclodextrin and pH was adjusted with 1 N NaOH.   
L822429 was injected i.p. at a volume of 2 ml/kg. 
METHODS
RESULTS
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Sucrose self adminsitration. L822429 (30 mg/kg) 
had no effect of sucrose self-administration (n=7/group).  
These results indicate that L822429 did not effect 
natural reward.
Stress-induced reinstatement. Two way ANOVA revealed 
main effects of session (p<0.001, n=13-14/group) and drug 
treatment (p<0.05), as well as an interaction (p<0.05).  Post-
hoc tests indicated a significant reinstatement in the vehicle 
group only. There was a decrease from vehicle reinstatement 
responding for both the 15 mg/kg and 30 mg/kg L822429 
treated groups. #p<0.05, ###p<0.001 compared to vehicle 
responding; ***p<0.001 compared to extinction responding.
Cue-induced reinstatement. Two way ANOVA 
revealed a main effect of session only (p<0.001, n=12-
13/group).  Post-hoc analysis indicated a significant 
increase from extinction responding during the 
reinstatement test for all treatment groups. *p<0.05, 






























Alcohol self administrati n. Two way ANOVA revealed a 
main effect of session only (p<0.01, n=11-12/group).  Post-hoc 
tests indicated a significant decrease from baseline in the 
number of rewards obtained on treatment day for the 30 
mg/kg L822429 treated group only (*p<0.05).  
1. Commons KG (2010) Neuronal pathways linking substance P to 
drug addiction and stress. Brain Research, 2010 Feb 16; 1314C: 
175-182.  Epub 2009 Nov 11.
2. Ebner K, Singewald N (2006) The role of substance P in stress 
and anxiety responses.  Amino Acids, 31: 251-272.
3. Gadd CA, Murtra P, De Felipe C, Hunt SP (2003) Neurokinin-1 
receptor-expressing neurons in the amygdala modulate morphine 
reward and anxiety behaviors in the mouse. Journal of 
Neuroscience, 23(23): 8271-8280.
4. Ripley TL, Gadd CA, De Felipe C, Hunt SP, Stephens DN (2002) 
Lack of self-administration and behavioural sensitisation to 
morphine, but not cocaine, in mice lacking NK1 receptors.  
Neuropharmacology 43: 1258-1268.
5. Murtra P, Sheasby AM, Hunt SP, De Felipe C (2000) Rewarding 
effects of opiates are absent in mice lacking the receptor for 
substance P.  Nature, 405: 180-183.
6. Thorsell A, Schank JR, Singley E, Hunt SP, Heilig M (2010) 
Neurokinin-1 receptors, alcohol consumption, and alcohol reward 
in mice.  Psychopharmacology (Berl), 2010 Mar; 209(1): 103-111.  
Epub 2010 Jan 30.
7. George DT, Gilman J, Hersh J, Thorsell A, Herion D, Geyer C, 
Peng X, Kielbasa W, Rawlings R, Brandt JE, Gehlert DR, 
Tauscher JT, Hunt SP, Hommer D, Heilig M (2008) Neurokinin 1 
receptor antagonism as a possible therapy for alcoholism. 
Science, 319: 1536-1539.
8. Singewald N, Chicchi GG, Thurner CC, Tsao K-L, Spetea M, 
Schmidhammer H, Sreepathi HK, Farraguti F, Singewald GM, 
Ebner K (2008) Modulation of basal and stress-induced 
amygdaloid substance P release by the potent and selective NK1 
receptor antagonist L-822429. Journal of Neurochemistry, 106: 
2476-2488.
9. Ebner K, Singewald GM, Whittle N, Ferraguti F, Singewald N 
(2008b) Neurokinin 1 receptor antagonism promotes active stress 
coping via enhanced septal 5HT transmission.  
Neuropsychopharmacology, 33: 1929-1941.
Extinction Reinstatement
0
5
10
15
20
25
 
 
** * *
A
ct
iv
e 
Le
ve
r 
R
es
po
ns
es
